Brainstorm Cell Therapeutics Inc. (BCLI) dropped -6.78% or -0.35 to $4.81. It is approximately 167742 shares traded, which is 80.9% compare to the average total volume 207340. The market cap of BCLI is $91.93 million. The year to date change is -636.93%. The 52 week price range is from $2.88 to $5.35. Price of BCLI have changed 3.20% during last week. It have changed 39.08% over last month, 52.21% over last 3 months, 27.72% over last 6 months and 27.72% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for BCLI is 3.75. It is -22.04% below current price. The 200-day Moving Averages for BCLI is 3.77. It is -21.62% below current price. The 52-week High is 5.35. It is 11.23% from the current price. The 52-week Low is 2.88. It is -40.12% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of BCLI is 16.61 on 2018-05-15. Short % to float is 8.64%. There are some statistics of BCLI. It is has market cap $91.93 million. The share outstanding is 19.11 million. The average volume is 207340. The percent of top 15 Institution holding is 8.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of BCLI is -81.73%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of BCLI is -55.02%.